# MAST - Magnesium for Sickle Cell Acute Crisis in Children

> **NCT00313963** · PHASE3 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 120 (actual)

## Conditions studied

- Anemia, Sickle Cell

## Interventions

- **DRUG:** Magnesium Sulfate
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT00313963
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-08
- **Final completion:** 2013-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2013-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00313963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00313963, "MAST - Magnesium for Sickle Cell Acute Crisis in Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00313963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*